Silver-CMC Wound Dressing for Stable Antimicrobial Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial wound dressings face issues with cytotoxicity, inadequate silver retention, and limited exudate absorption, leading to ineffective antimicrobial activity and potential health risks due to non-uniform silver nanoparticle distribution and high production costs.
Innovation Solution
A method involving the chemical bonding of silver ions to sodium carboxymethyl cellulose (CMC) to create a silver-CMC compound, which is then dispersed in a medium and dried to form a wound dressing with a pressure-sensitive adhesive layer and external protective film, ensuring stable antimicrobial activity and efficient exudate absorption without silver particle fallout.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver nanoparticles are used to provide antimicrobial activity, then antimicrobial effectiveness is improved, but cytotoxicity increases and silver particles fall off
Solution Approach 1:
The patent combines silver ions with carboxymethyl cellulose (CMC) to create a composite material where silver is chemically bonded to the polymer matrix. This composite structure maintains antimicrobial activity while reducing cytotoxicity and preventing silver particle fallout, as the silver is stabilized within the CMC network
Solution Approach 2:
The patent changes the physical and chemical parameters of silver from metallic nanoparticles to ionic form bonded to CMC. This parameter change from Ag⁰ to Ag⁺ state, combined with bonding to CMC, reduces cytotoxicity while maintaining antimicrobial effectiveness and preventing particle detachment
2Reliability
If silver content is increased to enhance antimicrobial activity, then antimicrobial effectiveness is improved, but production cost increases
Solution Approach 1:
The patent optimizes the silver content parameter to a specific range (0.1-10 ppm) and changes the form of silver from metallic to ionic bonded to CMC. This parameter optimization achieves effective antimicrobial activity at lower silver concentrations, reducing production costs while maintaining reliability
3Reliability
If silver nanoparticles are dispersed in wound dressing, then antimicrobial activity is provided, but silver distribution becomes non-uniform and particles fall off
Solution Approach 1:
The patent creates a composite material where silver ions are chemically bonded to the CMC polymer matrix through coordination bonds. This composite structure ensures uniform distribution of silver throughout the dressing and prevents particle fallout, as silver is stabilized within the polymer network rather than being loosely dispersed
Solution Approach 2:
The CMC polymer acts as an intermediary between silver ions and the wound dressing matrix. It mediates the distribution and retention of silver, ensuring uniform dispersion and preventing particle detachment through chemical bonding, thereby maintaining both antimicrobial activity and stability
4Ease of operation
If conventional wound dressings are used to absorb exudate, then moisture management is improved, but antimicrobial activity is insufficient
Solution Approach 1:
The patent merges the exudate absorption function of CMC with the antimicrobial function of silver ions into a single integrated dressing material. The CMC provides moisture management while bonded silver provides antimicrobial activity, combining both functions in one material system rather than separate components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The silver-CMC wound dressing provides effective antimicrobial activity against pathogenic bacteria, promotes wound healing by maintaining a moist environment, reduces cytotoxicity, and minimizes pain during dressing changes, while preventing silver penetration into the body.
Implementation Method 1
adding a silver-containing compound to a 0.1-30% aqueous solution of an alkaline solvent to dissociate silver ions from the silver-containing compound
Implementation Method 2
mixing the silver ion-containing solution with the CMC solution so that the hydrogen ions (H+) of the hydroxyl groups (OH-) of CMC are replaced by the silver ions
Implementation Method 3
sodium carboxymethyl cellulose (C 6 H 9 OCH 2 COONa, hereinafter abbreviated as CMC)
Data Source
Figure 1
Figure 2
Figure 3(a)~3(b)
AI summary
A method for producing a silver-bonded antimicrobial moist wound dressing. A silver- containing compound is added to a 0.1-30% aqueous solution of an alkaline solvent to dissociate silver ions from the silver-containing compound, dissolving CMC in water or an organic solvent to obtain a CMC solution, the silver ion-containing solution is mixed with the CMC solution so that the hydrogen ions (H+) of the hydroxyl groups of the CMC are replaced by the silver ions to prepare a silver-CMC compound, the silver-CMC compound is dispersed and absorbed in a medium, and the medium is dried.